[1] Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med 2016; 193(3): 259-72.
[2] Danielski LG, Giustina AD, Badawy M, Barichello T, Quevedo J, Dal-Pizzol F, Petronilho F. Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis. Mol Neurobiol. 2018;55(2):1045-1053.
[3] Schwalm MT, Pasquali M, Miguel SP, Dos Santos JP, Vuolo F, Comim CM, Petronilho F, Quevedo J, Gelain DP, Moreira JC, Ritter C, Dal-Pizzol F. Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats.Mol Neurobiol. 2014; 49(1):380-385.
[4] Hoogland ICM, Westhoff D, Engelen-Lee JY, Melief J, Valls Serón M, Houben-Weerts JHMP, Huitinga I, van Westerloo DJ, van der Poll T, van Gool WA, van de Beek D. Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli.Front Cell Neurosci. 2018;12:110.
[5] Henry CJ, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines. Brain Behav Immun. 2009; 23(3):309-317.
[6] Michels M, Danielski LG, Dal-Pizzol F, Petronilho F. Neuroinflammation: Microglial Activation During Sepsis. Curr Neurovasc Res. 2014; 11(3): 262-270.
[7] Rose-Marie B, Sophie L, Bruno M, Chantal C, Robert D, Patricia P. Role of interleukin-1b and tumour necrosis factor-a in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. European Journal of Neuroscience. 2000; 12: 4447-4456.
[8] Matt SM, Lawson MA, Johnson RW. Aging and peripheral lipopolysaccharide can modulate epigenetic regulators and decrease IL-1β promoter DNA methylation in microglia. Neurobiol Aging. 2016; 47:1-9.
[9] Nishioku T, Dohgu S, Takata F, Eto T, Ishikawa N, Kodama KB, Nakagawa S, Yamauchi A, Kataoka Y. Detachment of Brain Pericytes from the Basal Lamina is Involved in Disruption of the Blood-Brain Barrier Caused by Lipopolysaccharide-Induced Sepsis in Mice. Cell Mol Neurobiol. 2009; 29(3):309-316.
[10] Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N, Meabon JS, Wing EE, Morofuji Y, Cook DG, Reed MJ. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation. 2015;12:223.
[11] Chi JM, Mackay M, Hoang A, Cheng K, Aranow C, Ivanidze J, Volpe B, Diamond B, Sanelli PC. Alterations in Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus. AJNR Am J Neuroradiol. 2019; 40(3):470-477.
[12] Yu H, Hu Q, Sun J, Feng R, Zhang S, Zhang J, Mao XH, Ji S. Comprehensive Screening of Multi-components in Huangqi Injection by Ultra-performance Liquid Chromatography Coupled with Quadrupole-time-of-flight Mass Spectrometry. World Chinese Medicine. 2019;14(4): 809-817.
[13] Chen YB. Influence of Radix Astragali injection on imminologic function in septic patients. Medicine school of Zejiang University. 2008.
[14] Wu SX. The study of clinical effect of Astragalus injection treating critical sepsis patients. Guangzhou University of Chinese Medicine. 2013.
[15] Wang MS, Li J, Di HX, Li ZL, Yang SL, Hou W, Yan JY, Zhao XM. Clinical study on effect of Astragalus Injection and its immuno-regulation action in treating chronic aplastic anemia. Chin J Integr Med. 2007;13(2):98-102.
[16] Zhao P, Wang Y, Zeng S, Lu J, Jiang TM, Li YM. Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice. Immunopharmacol Immunotoxicol. 2015;37(5):428-433.
[17] Li L, Hou X, Xu R, Liu C, Tu M. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol. 2017;31(1):17-36.
[18] Zhou X, Sun X, Gong X, Yang Y, Chen C, Shan G, Yao Q. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.Int Immunopharmacol. 2017;42:18-24.
[19] Yang J, Wang HX, Zhang YJ, Yang YH, Lu ML, Zhang J, Li ST, Zhang SP, Li G. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy. J Ethnopharmacol. 2013;150(3): 1062-1070.
[20] Leng B, Tang F, Lu M, Zhang Z, Wang H, Zhang Y. Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway. Life Sci. 2018; 209:111-121.
[21] Heldt, S.A., Stanek, L., Chhatwal, J.P., Ressler, K.J., 2007. Hippocampus-specifific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol. Psychiatry 12, 656e670.
[22] Yao H, Gu LJ, Guo JY. Study on effect of astragali radix polysaccharides in improving learning and memory functions in aged rats and its mechanism. Zhongguo Zhong Yao Za Zhi. 2014 Jun;39(11):2071-2075.
[23] Tang Q, Ke H, Wu C, Zeng J, Li Z, Liu Y, Feng S, Xue Q, Xu X. Aqueous extract from You-Gui-Yin ameliorates cognitive impairment of chronic renal failure mice through targeting hippocampal CaMKIIα/CREB/BDNF and EPO/EPOR pathways. J Ethnopharmacol. 2019; 239:111925.
[24] Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848-858.
[25] Feng S, Zou L, Wang H, He R, Liu K, Zhu H. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability. Molecules. 2018; 23(9). pii: E2371.
[26] Hoogland IC, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D. Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation. 2015;12:114.
[27] Hoshino K, Hayakawa M, Morimoto Y. Minocycline Prevents the Impairment of Hippocampal Long-Term Potentiation in the Septic Mouse. Shock. 2017; 48(2):209-214.
[28] Reis PA, Alexandre PCB, D'Avila JC, Siqueira LD, Antunes B, Estato V, Tibiriça EV, Verdonk F, Sharshar T, Chrétien F, Castro-Faria-Neto HC, Bozza FA. Statins prevent cognitive impairment after sepsis by reverting neuroinflammation, and microcirculatory/endothelial dysfunction. Brain Behav Immun. 2017;60:293-303.
[29] Nishioku T, Dohgu S, Takata F, Eto T, Ishikawa N, Kodama KB, Nakagawa S, Yamauchi A, Kataoka Y. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice.Cell Mol Neurobiol. 2009; 29(3):309-316.
[30] Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.Pharmacol Ther. 2008; 117(1):30-51.
[31] Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry. 2007;12(7):656-670.
[33] Xenos D, Kamceva M, Tomasi S, Cardin JA, Schwartz ML, Vaccarino FM. Loss of TrkB Signaling in Parvalbumin-Expressing Basket Cells Results in Network Activity Disruption and Abnormal Behavior. Cereb Cortex. 2018;28(10):3399-3413.
[34] Koike H, Fukumoto K, Iijima M, Chaki S. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression. Behav Brain Res. 2013; 238:48-52.
[35] Adachi M, Autry AE, Mahgoub M, Suzuki K, Monteggia LM. TrkB Signaling in Dorsal Raphe Nucleus is Essential for Antidepressant Efficacy and Normal Aggression Behavior. Neuropsychopharmacology. 2017; 42(4):886-894.
[36] Jian LH, Xia J, Shen YY, Lin J, Wang K, Ji S. Study of relative molecular mass of polusaccharides in huangqi injection by high performance gelpermeation chromatography. Chin J Pharm Anal. 2010; 30(11): 2037-2039.